For PC-3 prostate cancer cells similar results were obtained concerning increase of receptor expression of DR4 and DR5 for resveratrol treatment with 10 μM and 20 μM for 48 h, and caspase 3/8 activation for treatment with resveratrol (0-30 μM) and in combination with TRAIL (25 nM). The gene discussed is TNFRSF10A; the disease is prostate carcinoma.